SCHEMBL3980466

SCHEMBL3980466

Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1C=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
PARP15 Q460N3 1/20 0.42
PARP10 Q53GL7 1/20 0.42
RXRA P19793 1/20 0.42
NR4A2 P43354 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
SRD5A2 P31213 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PPARG P37231 2/20 0.41
MAP4K4 O95819 1/20 0.41
LOXL2 Q9Y4K0 1/20 0.41
ALDH1A1 P00352 1/20 0.40
KDM4E B2RXH2 1/20 0.39
KMT2A Q03164 1/20 0.39
F2 P00734 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4597491 0.86 ALDH1A1 (0.53) TDP1CA1CA2CYP1A2CYP3A4
SCHEMBL4140304 0.83 KDM4E (0.46) PARP10SMN1; SMN2MAP4K4ALDH1A1KDM4E
SCHEMBL4597441 0.82 ALDH1A1 (0.39) CA1CA2CYP1A2CYP3A4CYP2C19
SCHEMBL4128161 0.82 F2 (0.47) SRD5A2PPARGKDM4EF2
SCHEMBL5575510 0.82 PTGDR2 (0.46) SMN1; SMN2ALDH1A1KDM4E
SCHEMBL5572824 0.81 KDM4E (0.43) TDP1CYP1A2CYP2C19SMN1; SMN2MAP4K4
SCHEMBL4598347 0.81 ALDH1A1 (0.50) CYP1A2CYP2C19MAP4K4ALDH1A1KDM4E
SCHEMBL13809841 0.81 MAP4K4 (0.40) PARP10CYP1A2CYP2C19MAP4K4ALDH1A1
SCHEMBL5575614 0.81 PTGS2 (0.43) CYP1A2
SCHEMBL5575305 0.80 KDM4E (0.42) TDP1CYP1A2CYP2C19SMN1; SMN2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009075960-A1 CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-18 WO disclosed
WO-2009075960-A1 CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2009-06-18 WO disclosed
WO-2009058924-A1 CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2009-05-07 WO disclosed
WO-2009058924-A1 CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2009-05-07 WO disclosed